Mo Li

1.1k total citations · 1 hit paper
31 papers, 717 citations indexed

About

Mo Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mo Li has authored 31 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Mo Li's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Mo Li is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Mo Li collaborates with scholars based in China, United States and Japan. Mo Li's co-authors include Yinan Xiao, Hongyan Guo, Bingteng Xie, Jihong Ma, Haowei Meng, Bo Lu, Chenxu Zhu, Jinghui Song, Yuan Zhuang and Chengqi Yi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cancer Research.

In The Last Decade

Mo Li

29 papers receiving 712 citations

Hit Papers

KAT8-catalyzed lactylation promotes eEF1A2-mediated prote... 2024 2026 2025 2024 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis
    2024 134 citations Bingteng Xie, Jihong Ma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mo Li China 13 500 207 91 71 66 31 717
Katarzyna Kulcenty Poland 17 377 0.8× 156 0.8× 192 2.1× 92 1.3× 54 0.8× 48 766
Chunbo He China 14 505 1.0× 153 0.7× 134 1.5× 87 1.2× 111 1.7× 35 886
Qiyi Yi China 16 358 0.7× 190 0.9× 100 1.1× 86 1.2× 29 0.4× 29 594
Beibei Liu China 13 477 1.0× 225 1.1× 164 1.8× 65 0.9× 38 0.6× 46 711
Godfrey Grech Malta 15 533 1.1× 212 1.0× 154 1.7× 44 0.6× 75 1.1× 47 855
Xinping Huang China 17 532 1.1× 218 1.1× 154 1.7× 96 1.4× 43 0.7× 28 796
Andrew Trotta Australia 13 453 0.9× 154 0.7× 125 1.4× 92 1.3× 84 1.3× 17 693
Elena Cavadini Italy 19 669 1.3× 163 0.8× 160 1.8× 103 1.5× 104 1.6× 30 877

Countries citing papers authored by Mo Li

Since Specialization
Citations

This map shows the geographic impact of Mo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Li more than expected).

Fields of papers citing papers by Mo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Li. The network helps show where Mo Li may publish in the future.

Co-authorship network of co-authors of Mo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Li. A scholar is included among the top collaborators of Mo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Li. Mo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mo, et al.. (2024). Quantitative analysis of immune cells within the tumor microenvironment of glioblastoma and their relevance for prognosis. International Immunopharmacology. 142(Pt A). 113109–113109. 4 indexed citations
2.
Wu, Zhenxu, Mo Li, Zongliang Wang, et al.. (2024). Biointerface engineering through amalgamation of gene technology and site‐specific growth factor conjugation for efficient osteodifferentiation. Biotechnology and Bioengineering. 122(1). 80–94.
3.
Zhang, Xiaofang, Xiaofang Che, Sibo Zhang, et al.. (2024). Mesenchymal stem cell-derived extracellular vesicles for human diseases. PubMed. 5(1). 64–82. 10 indexed citations
4.
5.
Yue, Wei, Xinyu Li, Lei Wang, et al.. (2024). PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response. EBioMedicine. 103. 105129–105129. 4 indexed citations
6.
Wang, Yuqian, Zhenzhen Zhang, Hanqing He, et al.. (2023). Aging-induced pseudouridine synthase 10 impairs hematopoietic stem cells. Haematologica. 108(10). 2677–2689. 5 indexed citations
7.
Wang, Pan, Jihong Ma, Qilong Wang, et al.. (2023). Profiling the metabolome of uterine fluid for early detection of ovarian cancer. Cell Reports Medicine. 4(6). 101061–101061. 18 indexed citations
8.
Xie, Bingteng, Yang Pu, Fan Yang, et al.. (2022). Proteomic Mapping and Targeting of Mitotic Pericentriolar Material in Tumors Bearing Centrosome Amplification. Cancer Research. 82(14). 2576–2592. 11 indexed citations
9.
10.
Yan, Yan, Yan Cheng, Mo Li, et al.. (2022). The Differential Expression of Circular RNAs in Type 2 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults. Genetic Testing and Molecular Biomarkers. 26(3). 118–126. 1 indexed citations
11.
Guo, Qian, Linjing Li, Mo Li, et al.. (2022). Integrated Traditional Chinese Medicine Improves Functional Outcome in Acute Ischemic Stroke: From Clinic to Mechanism Exploration With Gut Microbiota. Frontiers in Cellular and Infection Microbiology. 12. 827129–827129. 20 indexed citations
12.
Hu, Fan, et al.. (2021). SOX‐17 is involved in invasion and apoptosis of colorectal cancer cells through regulating miR‐302b‐3p expression. Cell Biology International. 45(6). 1296–1305. 3 indexed citations
13.
Du, Hongqiang, Huawei Xia, Tongtong Liu, et al.. (2021). Suppression of ELF4 in ulcerative colitis predisposes host to colorectal cancer. iScience. 24(3). 102169–102169. 16 indexed citations
14.
Bai, Lijun, et al.. (2021). Inflammatory microenvironment-targeted nanotherapies. Journal of Controlled Release. 334. 114–126. 40 indexed citations
15.
Zhang, Na, Rui Yang, Yanyan Shi, et al.. (2021). Mitochondrial proteome of mouse oocytes and cisplatin-induced shifts in protein profile. Acta Pharmacologica Sinica. 42(12). 2144–2154. 8 indexed citations
16.
Li, Wenjing, Xiaoyang Gu, Chunhong Liu, et al.. (2021). A synergetic effect of BARD1 mutations on tumorigenesis. Nature Communications. 12(1). 1243–1243. 18 indexed citations
17.
Wu, Yue, Fan Hu, Mei Li, et al.. (2020). Delivery of BR2‐SOX17 fusion protein can inhibit cell survival, proliferation, and invasion in gastric cancer cells through regulating Klotho gene expression. Cell Biology International. 44(10). 2011–2020. 9 indexed citations
18.
Hu, Fan, Mei Li, Mo Li, et al.. (2020). Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells. Translational Cancer Research. 9(4). 2638–2647. 14 indexed citations
19.
Wang, Xuzhao, Yafei Chen, Yuhong Zhang, et al.. (2017). Eag1 Voltage-Dependent Potassium Channels: Structure, Electrophysiological Characteristics, and Function in Cancer. The Journal of Membrane Biology. 250(2). 123–132. 20 indexed citations
20.
Liu, Zhaoyang, Hai-mei Tian, Hui Li, et al.. (2002). Antitumor effect of BRM. Chinese Journal of Cancer Research. 14(3). 195–201. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Kulcenty Breakdown of academic impact, for papers by Chunbo He Breakdown of academic impact, for papers by Qiyi Yi Breakdown of academic impact, for papers by Beibei Liu Breakdown of academic impact, for papers by Godfrey Grech Breakdown of academic impact, for papers by Xinping Huang Breakdown of academic impact, for papers by Andrew Trotta Breakdown of academic impact, for papers by Elena Cavadini
Rankless by CCL
2026